1. Home
  2. TTC vs MDGL Comparison

TTC vs MDGL Comparison

Compare TTC & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Toro Company (The)

TTC

Toro Company (The)

HOLD

Current Price

$94.15

Market Cap

9.3B

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$520.17

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTC
MDGL
Founded
1914
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Tools/Hardware
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
10.0B
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
TTC
MDGL
Price
$94.15
$520.17
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$104.00
$674.45
AVG Volume (30 Days)
976.5K
294.7K
Earning Date
03-05-2026
04-30-2026
Dividend Yield
1.66%
N/A
EPS Growth
N/A
41.32
EPS
0.69
N/A
Revenue
$2,618,650,000.00
$180,133,000.00
Revenue This Year
$6.11
$58.28
Revenue Next Year
$4.45
$46.80
P/E Ratio
$136.06
N/A
Revenue Growth
4.53
N/A
52 Week Low
$62.34
$265.00
52 Week High
$105.19
$615.00

Technical Indicators

Market Signals
Indicator
TTC
MDGL
Relative Strength Index (RSI) 42.83 72.06
Support Level $76.60 $411.87
Resistance Level $102.32 $610.00
Average True Range (ATR) 2.41 23.48
MACD -0.47 8.44
Stochastic Oscillator 22.78 65.23

Price Performance

Historical Comparison
TTC
MDGL

About TTC Toro Company (The)

The Toro Co designs, manufactures, markets, and sells professional turf maintenance equipment and services; turf and agricultural irrigation systems; landscaping equipment and lighting products; snow and ice management equipment; construction equipment; and residential yard and snow thrower products. The company operates through Professional and Residential segments, with the Professional segment serving commercial, agricultural, and construction customers and generating the majority of revenue, while the Residential segment focuses on homeowners. Its products are sold through distributors, dealers, retailers, rental centers, and direct channels, with the United States as its primary revenue-generating market.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: